Chemocentryx Inc. buy PlusUltra
Start price
17.10.21
/
0%
€29.43
Target price
17.10.22
-
Performance (%)
72.85%
End price
15.09.22
€50.87
Summary
This prediction ended on 15.09.22 with a price of €50.87. With a performance of 72.85% the BUY prediction by PlusUltra was a big success. This prediction was marked as speculative and is excluded from PlusUltra's performance statistics.Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Chemocentryx Inc. | - | - | - | - |
| iShares Core DAX® | 0.734% | 1.458% | 17.980% | 65.292% |
| iShares Nasdaq 100 | -2.686% | -0.146% | 3.810% | 97.467% |
| iShares Nikkei 225® | -2.261% | -2.729% | 11.679% | 39.755% |
| iShares S&P 500 | -1.346% | 0.467% | 1.970% | 61.093% |
According to PlusUltra what are the pros and cons of Chemocentryx Inc. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Capable Management
Innovative
Top 10 in its market
Cons
Comments by PlusUltra for this prediction
In the thread Discuss Chemocentryx Inc.
Buy Chemocentryx Inc.